Fingerprint
Dive into the research topics of 'Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma
Andrew Gabrielson, Anteneh A. Tesfaye, John L. Marshall, Michael J. Pishvaian, Brandon Smaglo, Reena Jha, Karen Dorsch-Vogel, Hongkun Wang, Aiwu Ruth He
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations